- Home
- USAS vs ORIC Comparison
USAS vs ORIC Comparison
Compare USAS & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USAS
- ORIC
- Stock Information
- Founded
- USAS 1998
- ORIC 2014
- Country
- USAS Canada
- ORIC United States
- Employees
- USAS N/A
- ORIC N/A
- Industry
- USAS Metal Mining
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- USAS Basic Materials
- ORIC Health Care
- Exchange
- USAS Nasdaq
- ORIC Nasdaq
- Market Cap
- USAS 1.1B
- ORIC 1.1B
- IPO Year
- USAS N/A
- ORIC 2020
- Fundamental
- Price
- USAS $3.65
- ORIC $11.54
- Analyst Decision
- USAS Strong Buy
- ORIC Strong Buy
- Analyst Count
- USAS 2
- ORIC 11
- Target Price
- USAS $4.08
- ORIC $18.78
- AVG Volume (30 Days)
- USAS 3.1M
- ORIC 1.1M
- Earning Date
- USAS 11-10-2025
- ORIC 11-13-2025
- Dividend Yield
- USAS N/A
- ORIC N/A
- EPS Growth
- USAS N/A
- ORIC N/A
- EPS
- USAS N/A
- ORIC N/A
- Revenue
- USAS $104,867,000.00
- ORIC N/A
- Revenue This Year
- USAS $26.26
- ORIC N/A
- Revenue Next Year
- USAS $67.48
- ORIC N/A
- P/E Ratio
- USAS N/A
- ORIC N/A
- Revenue Growth
- USAS N/A
- ORIC N/A
- 52 Week Low
- USAS $0.87
- ORIC $3.90
- 52 Week High
- USAS $5.12
- ORIC $14.93
- Technical
- Relative Strength Index (RSI)
- USAS 43.99
- ORIC 40.39
- Support Level
- USAS $3.64
- ORIC $11.28
- Resistance Level
- USAS $4.04
- ORIC $12.50
- Average True Range (ATR)
- USAS 0.28
- ORIC 0.82
- MACD
- USAS -0.07
- ORIC -0.16
- Stochastic Oscillator
- USAS 12.39
- ORIC 22.22
About USAS Americas Gold and Silver Corporation no par value
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.